<DOC>
	<DOCNO>NCT00718003</DOCNO>
	<brief_summary>The literature date indicate noninvasive positive pressure ventilation ( NIPPV ) provide effective noninvasive ventilator support , prolongs survival , improve quality life ( QOL ) Amyotrophic Lateral Sclerosis ( ALS ) patient . It generally recommend patient pulmonary function test demonstrate drop 50 % forced vital capacity ( FVC ) . One result use NIPPV may reduction work breathe would lead decreased caloric need . However , work breathing effect noninvasive ventilation caloric use study patient ALS . This extremely important since may reduction caloric need ALS patient place NIPPV caloric intake adjust , overfeed occur . Overfeeding many calorie lead increase carbon dioxide would actually worsen respiratory failure . The overall aim project evaluate many calorie use ALS patient rest , place NIPPV , breathe resistance . This accomplish use metabolic cart activity . At present , metabolic cart routinely used ALS patient time feed tube placement calculate caloric need . Using cart calculate caloric expenditure ventilator aid calculate work breathe effect NIPPV work breathing .</brief_summary>
	<brief_title>Noninvasive Examination Work Breathing Patients With Amyotrophic Lateral Sclerosis ( ALS ) .</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>Patients probable definite ALS El Escorial Criteria age 2085 included evaluation . They must progression disease precede 6 month duration disease less 5 year . Patients meet clinical criterion diagnosis include pure upper motor neuron syndrome ( PLS ) pure lower motor syndrome ( SMA , Multifocal conduction block , motor neuropathy ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Cerebrospinal Fluid</keyword>
	<keyword>Neurodegenerative Disease</keyword>
	<keyword>Motor Neuron Disease</keyword>
	<keyword>Autonomic Nervous System</keyword>
	<keyword>Neurodegenerative Diseases</keyword>
	<keyword>Movement Disorders</keyword>
</DOC>